Several experimental data showed that the inhibition of iNOS could be an important therapeutic target to treat septic shock patients and that the adhesion molecules (such as ICAM-1) have been related with the gravity of the sepsis syndrome [26, 27]. The gene discussed is ICAM1; the disease is septic shock.